Filtered By:
Management: Food and Drug Administration (FDA)
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 341 results found since Jan 2013.
The Price of Progress or the Waste of Regulation?
The average cost of delivering a new therapy from laboratory to clinic is increasing at a fast pace, more than doubling since the turn of the century according to some studies, to stand at $2.5 billion or more. This is not driven by the work of research and development becoming more expensive: if anything, the price of the tools of biotechnology is in free fall, even as capacity increases by orders of magnitude. Biotechnology has gone through, and is still going through, its own echoed version of the computing revolution of recent decades. A mix of advances in computational power and materials science means that a graduate...
Source: Fight Aging! - September 7, 2018 Category: Research Authors: Reason Tags: Of Interest Source Type: blogs
Fight Aging! Newsletter, September 3rd 2018
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more.
This content is...
Source: Fight Aging! - September 2, 2018 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Fight Aging! Newsletter, August 27th 2018
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more.
This content is...
Source: Fight Aging! - August 26, 2018 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Clearing Senescent Cells from the Brain Reduces Tau Aggregation and Improves Function in Mouse Models of Alzheimer ' s Disease
Over the past few years researchers have demonstrated, numerous times, that using senolytic therapies to remove a significant fraction of senescent cells from old tissues in mice can reverse aspects of aging, successfully treat multiple age-related diseases that presently have no viable treatment options, and extend healthy life. In an exciting recent addition to this field of research, scientists used the dasatinib and quercetin combination in mouse models of Alzheimer's disease. The result is a restoration of function and a reduction of the characteristic tau aggregation that is a feature of this condition. The researche...
Source: Fight Aging! - August 23, 2018 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs
Why Oncologists Should Decline to Participate in the Right to Try Act
I just published my 8th Law and Ethics in Oncology column in the ASCO Post: "Why Oncologists Should Decline to Participate in the Right to Try Act."
On May 30, 2018, President Donald J. Trump signed into law the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017. This law creates an additional and alternative pathway for patients with a “life-threatening disease or condition” to access investigational medicines outside the clinical trial system. Since there are more than 1,100 cancer medicines currently under investigation, this law will materially impac...
Source: blog.bioethics.net - August 11, 2018 Category: Medical Ethics Authors: Thaddeus Mason Pope, JD, PhD Tags: Health Care syndicated Source Type: blogs
Magtrace Nanoparticles for Sentimag System is FDA Approved for Breast Lymph Node Biopsy
The Food and Drug Administration approved Endomagnetics Inc.’s magnetic tracer injection and detection system for guiding lymph node biopsies in patients with breast cancer undergoing mastectomy. In the procedure, the clinician injects a soluti...
Source: Medgadget - July 30, 2018 Category: Medical Devices Authors: Ben Ouyang Tags: Oncology Surgery Source Type: blogs
Methadone and Mixed Messages
As a physician licensed to prescribe narcotics, I am legally permitted to prescribe the powerful opioid methadone (also known by the brand name Dolophine ) to my patients suffering from severe, intractable pain that hasn ’t been adequately controlled by other, less powerful pain killers. Most patients I encounter who might fall into that category are likely to be terminal cancer patients. I’ve often wondered why I am approved to prescribe methadone to my patients as a treatment for pain, but I am not allowed to prescribe methadone to taper my patients off of a physical dependence they may have developed from lo...
Source: Cato-at-liberty - July 13, 2018 Category: American Health Authors: Jeffrey A. Singer Source Type: blogs
Healthy lifestyle: 5 keys to a longer life
How is it that the United States spends the most money on healthcare, and yet still has the one of the lowest life expectancies of all developed nations? (To be specific: $9,400 per capita, 79 years, and 31st.)
Maybe those of us in healthcare have been looking at it all wrong, for too long.
Healthy lifestyle and longevity
Researchers from the Harvard T.H. Chan School of Public Health conducted a massive study of the impact of health habits on life expectancy, using data from the well-known Nurses’ Health Study (NHS) and the Health Professionals Follow-up Study (HPFS). This means that they had data on a huge number of peo...
Source: Harvard Health Blog - July 5, 2018 Category: Consumer Health News Authors: Monique Tello, MD, MPH Tags: Health Prevention Source Type: blogs
T2 Bacterial Panel Obtain FDA Approval; Provides Rapid Diagnosis of Sepsis
There is exciting news in the area of clinical bacteriology. The FDA has approved the T2 Biosystems bacterial panel for the rapid detection of septicemia (see: T2 Biosystems Receives FDA Clearance to Market T2Bacteria Panel for Detection of Sepsis-Causing Pathogens), Below is an excerpt from the article:T2 Biosystems...announced that it has received market clearance from the U.S. Food and Drug Administration (FDA) for the T2 Bacteria Panel for the direct detection of bacterial species in human whole blood specimens from patients with suspected bloodstream infections. The T2Bacteria Panel... provides sensitive d...
Source: Lab Soft News - July 3, 2018 Category: Laboratory Medicine Authors: Bruce Friedman Tags: Clinical Lab Industry News Clinical Lab Testing Cost of Healthcare Food and Drug Administration Lab Industry Trends Medical Research Quality of Care Source Type: blogs
Fight Aging! Newsletter, June 4th 2018
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more.
This content is...
Source: Fight Aging! - June 3, 2018 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
The AMA Gets it Right by Defending Evidence-Based Medicine and Patient, Physician Autonomy
Gun control advocates like to accuse legislators of being “afraid of the NRA,” implying that reason and principle have nothing to do with their legislative decisions. In the same way, Jackie Kucinich, in a column in The Daily Beast, suggests that the failure of Congress to pass CARA 2.0 (Comprehensive Addiction and Recovery Act) is due primarily to the lobbying clout of the American Medical Association, pointing to its status as the “seventh highest lobbying spender in 2017.” The article quotes opioid reform advocate Gary Mendell as saying “the AMA will resist anything that regulates healthcare”—an inter...
Source: Cato-at-liberty - May 30, 2018 Category: American Health Authors: Jeffrey A. Singer Source Type: blogs
New At-Home Lab Testing Device Provides CBC Counts for Cancer Patients
I have been closely tracking the development of new at-home lab testing devices because I think, accompanied by expanded telemedicine choices, the face of healthcare will be changed forever. A recent article inDark Daily announced such a device for complete blood counts (CBC) (see:New At-Home CBC Device Enables Complete Blood Testing for Cancer Treatments and Biological/Viral Monitoring). Below is an excerpt from it:.....[N]ew devices that enable chronic disease patients to monitor and report findings to care providers continue to be developed and embraced by healthcare consumers. One such device fromAthelas, a diagn...
Source: Lab Soft News - May 15, 2018 Category: Laboratory Medicine Authors: Bruce Friedman Tags: Clinical Lab Industry News Clinical Lab Testing Cost of Healthcare Food and Drug Administration Healthcare Information Technology Lab Industry Trends Lab Processes and Procedures Medical Consumerism Point-of-Care Testing Test Kits and Ho Source Type: blogs
The Other Opioid Crisis: Hospital Shortages Lead To Patient Pain, Medical Error
I came across this public-accesss story, and wanted to share the perspective:
Pauline Bartolone, Kaiser Health News
Even as opioids flood American communities and fuel widespread addiction, hospitals are facing a dangerous shortage of the powerful painkillers needed by patients in acute pain, according to doctors, pharmacists and a coalition of health groups.
The shortage, though more significant in some places than others, has left many hospitals and surgical centers scrambling to find enough injectable morphine, Dilaudid and fentanyl — drugs given to patients undergoing surgery, fighting cancer or suffering traumatic i...
Source: Suboxone Talk Zone - March 26, 2018 Category: Addiction Authors: Jeffrey Junig MD PhD Tags: Acute Pain Anesthesia Public policy surgery Chronic pain opioid addiction Source Type: blogs
